Lv1
20 积分 2025-03-03 加入
TB and COPD in low-income settings: a collision of old foes
1小时前
待确认
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma
3个月前
已完结
Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price. Int J Clin Pharm
3个月前
已完结
皖公网安备34019202002308
